Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat

Sin‐Hee Park(Inserm), Valérie B. Schini‐Kerth(Université de Strasbourg)
Cardiovascular Diabetology
February 18, 2020
Cited by 128


Related Papers